Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, is scheduled to present and host investor meetings at the...

One-Person, One-Lever Setup To Become New Industry Standard NASHVILLE, Tenn. and DENVER, June 8, 2022 /PRNewswire/ -- Gathr Outdoors, a family of outdoor, camp and recreation brands committed to...

- Presentations Showcase Eiger's Innovative Therapies for Hepatitis Delta Virus PALO ALTO, Calif., June 8, 2022 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage...

Heidrick & Struggles (Nasdaq: HSII) today announced that Chief Financial Officer Mark Harris will present at the Sidoti Virtual Investor Conference on Wednesday, June 15, 2022. The presentation is...

-Analysis demonstrating highly accurate detection (AUC ≥ 0.94) of HCC vs. Healthy in two independently tested, diverse cohorts of patients -Analysis demonstrating highly accurate detection (AUC...